This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly ...
Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...
Semaglutide is the active ingredient in certain brand-name medications prescribed for obesity, type 2 diabetes, and more. Semaglutide belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist ...
Learn how the two forms of semaglutide compare in treating type 2 diabetes and supporting weight loss, plus their dosing ...
“Semaglutide is very effective for weight loss,” says Dr. Saunders. In fact, a 2021 phase 3 clinical trial found that 2.4 ...
Learn how to transition from injectable GLP-1s to oral options like Wegovy and Foundayo, with expert advice on dosing, side ...
Apo-Semaglutide Injection™ is administered using a prefilled pen with instructions for use consistent with brand‑name semaglutide, supporting familiarity for patients and health care professionals, ...